Medicare Proposes to Cover Aduhelm Only for Patients in Clinical Trials
If the preliminary decision is finalized this spring, it would sharply limit the number of patients who use the expensive drug.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.